Jason Gardner Net Worth & Insider Trades
Jason Gardner - See Remarks, Magenta Therapeutics, Inc
What is Jason Gardner's Net Worth?
The current estimated net worth of Magenta Therapeutics, Inc's See Remarks, Jason Gardner, is estimated to be about $2.24M . Jason Gardner owns about 645,964 units of Magenta Therapeutics, Inc common stock. In the last 4 years at Magenta Therapeutics, Inc, Jason Gardner has sold an estimated value of $1.79M worth.
What is Jason Gardner's Past Insider Trading?
Jason Gardner's largest purchase order was 47,796 units , worth over $6K on June 27, 2018. Jason Gardner's largest sale order was 76,711 units , worth over $1.16M on December 20, 2019. In total, Jason Gardner has made about 17 transactions over 4 years of their time at Magenta Therapeutics, Inc. Jason Gardner usually trades in February, with the busiest year in 2019. The most recent transaction was a sale order of 14,340 units , worth over $96.51K on September 20, 2021.
Jason Gardner
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Jason Gardner's Salary in 2020?
As See Remarks of Magenta Therapeutics, Inc, Jason Gardner has a total base salary of $530,000 . Jason Gardner received compensation valued at about $3,102,848 in 2020 after becoming See Remarks. The vast majority of their compensation came in the form of option awards of $2,309,592 , other earnings, plans or compensations of $262,000 , and other compensation of $1,256 .
What is Jason Gardner's' Mailing Address?
- Mailing address is C/o Magenta Therapeutics 50 Hampshire Street Cambridge MA 02139 MA
Magenta Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Jason Gardner, D.Phil. | 2020 | $530,000 | - | $2,309,592 | $262,000 | $1,256 | $3,102,848 |
| Jason Gardner, D.Phil. | 2019 | $515,000 | - | $903,764 | $231,750 | $487 | $1,651,001 |
| John C. Davis, Jr., M.D. | 2020 | $445,376 | - | $1,153,528 | $162,000 | $1,256 | $1,762,160 |
| John C. Davis, Jr., M.D. | 2019 | $417,000 | - | $345,899 | $150,120 | $502 | $913,521 |
| Stephen F. Mahoney | 2020 | $70,000 | - | $1,888,655 | - | $475 | $1,959,130 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1690585/000119312521123656/d32109ddef14a.htm
What are Magenta Therapeutics, Inc's Past Insider Trades?
Magenta Therapeutics, Inc's most recent insider trade came on September 20, 2021 by Kristen Stants who sold 5,736 units worth $38.6K . In the last 3 years, insiders at Magenta Therapeutics, Inc have sold an estimated value of $4.21M and bought an estimated value of $10.44M worth of shares. Insider trading is most common in June, with the busiest year in 2021 and 2019. The most active traders at the company are Jason Gardner, See Remarks, Michael P Cooke, Chief Scientific Officer, and Lisa Olson, See Remarks .
Magenta Therapeutics, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||